REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 4th, 2022 • Panacea Life Sciences Holdings, Inc. • Medicinal chemicals & botanical products • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 3, 2022, between Panacea Life Sciences Holdings, Inc., a Nevada corporation (the “Company”), and FirstFire Global Opportunities Fund, LLC, a Delaware limited liability company (the “Holder”).
WARRANT TO PURCHASE COMMON STOCK OF PANACEA LIFE SCIENCES HOLDINGS, INC.Panacea Life Sciences Holdings, Inc. • March 4th, 2022 • Medicinal chemicals & botanical products
This Warrant may be exercised in accordance with its terms at any time on or after the Initial Exercise Date and on or prior to 5:00 p.m. (New York City time) on May 18, 2027 (the “Termination Date”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b) of this Warrant.
SENIOR CONVERTIBLE NOTE OF PANACEA LIFE SCIENCES HOLDINGS, INC.Panacea Life Sciences Holdings, Inc. • March 4th, 2022 • Medicinal chemicals & botanical products • New York
This Senior Convertible Note (including all Senior Convertible Notes issued in exchange, transfer or replacement hereof, this “Note” (the “Other Notes”) is issued pursuant to the Exchange Agreement, dated as of March 3, 2023, between the Company and the Holder. Certain capitalized terms used herein are defined in Section 26 of this Note. Capitalized terms used, but not otherwise defined herein, shall have the meaning set forth in that certain Securities Purchase Agreement dated as of November 30, 2021 between the Company and Lincoln Park Capital Fund, LLC (the “Purchase Agreement).
EXCHANGE AGREEMENTExchange Agreement • March 4th, 2022 • Panacea Life Sciences Holdings, Inc. • Medicinal chemicals & botanical products • New York
THIS EXCHANGE AGREEMENT (the “Agreement”) is made as of the 3rd day of March, 2022 by and between Panacea Life Sciences Holdings, Inc., a Nevada corporation (the “Company”), and the holder signatory hereto (the “Holder”).
